Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LICC: Tecemotide in Colorectal Cancer After Liver Metastasis Resection
NCT01462513Phase 2Completed
- Start
- Aug 2011
- Primary completion
- Dec 2017
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of tecemotide in colorectal carcinoma (CRC). Started Aug 2011; status: completed.
02
Drugs
tecemotide
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT01462513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462513.